EJCTS Click here to go to Edwards website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Christos Alexiou
David Beggs
Fayek D. Salama
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alexiou, C.
Right arrow Articles by Salama, F. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alexiou, C.
Right arrow Articles by Salama, F. D.
Related Collections
Right arrow Lung - cancer

Eur J Cardiothorac Surg 2001;20:476-480
© 2001 Elsevier Science NL

Pneumonectomy for non-small cell lung cancer: predictors of operative mortality and survival

Christos Alexiou, David Beggs, Mark L. Rogers, Lynda Beggs, Sanjay Asopa, Fayek D. Salama

Department of Cardiothoracic Surgery, City Hospital, Nottingham, NG5 1PB, UK

Received 2 October 2000; received in revised form 22 May 2001; accepted 25 May 2001.

Corresponding author. Tel.: +44-0115-969-1169; ext 46397
e-mail: david.beggs{at}pipex.dial.com

Objective: The purpose of this study was to identify predictors of operative mortality and survival following pneumonectomy for non-small cell lung cancer (NSCLC). Methods: All 206 patients having a pneumonectomy for NSCLC between 1991 and 1997 in our unit were prospectively studied. There were 162 males (79%) and 44 females (21%) with a mean age (± standard deviation) of 61±7.7 years (range 34–81 years). Squamous cell (75%) and adenocarcinoma (17.0%) were the predominant histological types. The possible impact of 29 parameters on operative mortality and survival was tested with univariate and multivariate analysis. The mean follow-up was 2.3±1.2 years, ranging between 0 and 6.8 years, and it was complete. Results: Operative mortality was 6.8% (14 deaths). On multiple logistic regression older age (P=0.04) and the development post-operatively of bronchopleural fistula (BPF) (P=0.01) were independent predictors of operative mortality. The overall, Kaplan–Meier, 1-, 3- and 5-year survival (± standard error from the mean), inclusive of operative mortality, was 68±3.3, 42±4.1 and 35±4.5%. On Cox proportional hazards regression adenocarcinoma (P=0.006), the development of BPF (P=0.003), older age (P=0.03) and higher pathological stage (P=0.02) were independent adverse predictors of survival. Conclusion: Pneumonectomy for NSCLC carries a considerable, but acceptable, operative mortality and provides an important survival benefit. This study suggests that older age and BPF are major determinants of an unfavourable in-hospital outcome; older age, BPF, adenocarcinoma cell type and higher pathological stage significantly reduce the probability of a long-term survival.

Key Words: Pneumonectomy • operative mortality • survival




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
T. A. d'Amato, A. S. Ashrafi, M. J. Schuchert, D. S.A. Alshehab, A. J.E. Seely, F. M. Shamji, D. E. Maziak, S. R. Sundaresan, P. F. Ferson, J. D. Luketich, et al.
Risk of pneumonectomy after induction therapy for locally advanced non-small cell lung cancer.
Ann. Thorac. Surg., October 1, 2009; 88(4): 1079 - 1085.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. W. Kim, L. P. Faber, W. H. Warren, S. Basu, S. C. Wightman, J. A. Weber, P. Bonomi, and M. J. Liptay
Pneumonectomy after chemoradiation therapy for non-small cell lung cancer: does "side" really matter?
Ann. Thorac. Surg., September 1, 2009; 88(3): 937 - 943.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
E. J. Veen, M. L.G. Janssen-Heijnen, E. D. Ritchie, B. Biesma, M. P.H. van den Bogart, and R. Jan Bolhuis
Pneumonectomy for bronchogenic carcinoma: analysis of factors predicting short- and long-term outcome
Interactive CardioVascular and Thoracic Surgery, August 1, 2009; 9(2): 260 - 264.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Gudbjartsson, E. Gyllstedt, A. Pikwer, and P. Jonsson
Early Surgical Results After Pneumonectomy for Non-Small Cell Lung Cancer are not Affected by Preoperative Radiotherapy and Chemotherapy
Ann. Thorac. Surg., August 1, 2008; 86(2): 376 - 382.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
N. Ramnath, T. L. Demmy, A. Antun, N. Natarajan, C. E. Nwogu, G. M. Loewen, and M. E. Reid
Pneumonectomy for Bronchogenic Carcinoma: Analysis of Factors Predicting Survival
Ann. Thorac. Surg., May 1, 2007; 83(5): 1831 - 1836.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
A. Shaw
Genetics of postoperative complications following thoracic surgery.
Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2006; 10(4): 327 - 345.
[Abstract] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
H. Rostad, T.-E. Strand, A. Naalsund, O. Talleraas, and J. Norstein
Lung cancer surgery: the first 60 days. A population-based study.
Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 824 - 828.
[Abstract] [Full Text] [PDF]


Home page
ICVTSHome page
M. Dancewicz, J. Kowalewski, and J. Peplinski
Factors associated with perioperative complications after pneumonectomy for primary carcinoma of the lung
Interactive CardioVascular and Thoracic Surgery, April 1, 2006; 5(2): 97 - 100.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
E. Perrot, B. Guibert, P. Mulsant, S. Blandin, I. Arnaud, P. Roy, L. Geriniere, and P.-J. Souquet
Preoperative Chemotherapy Does Not Increase Complications After Nonsmall Cell Lung Cancer Resection
Ann. Thorac. Surg., August 1, 2005; 80(2): 423 - 427.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
C. Alexiou, D. Beggs, P. Onyeaka, K. Kotidis, S. Ghosh, L. Beggs, D. N. Hopkinson, J. P. Duffy, W. E. Morgan, and G. Rocco
Pneumonectomy for Stage I (T1N0 and T2N0) nonsmall cell lung cancer has potent, adverse impact on survival
Ann. Thorac. Surg., October 1, 2003; 76(4): 1023 - 1028.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
R Booton, M Jones, and N Thatcher
Lung cancer * 7: Management of lung cancer in elderly patients
Thorax, August 1, 2003; 58(8): 711 - 720.
[Full Text] [PDF]


Home page
ICVTSHome page
G. Varela, M. F. Jimenez, N. Novoa, and P. Macri
Discordance between predicted postoperative forced expiratory volumes in one second (ppoFEV1) calculated before and after resection of bronchogenic carcinoma
Interactive CardioVascular and Thoracic Surgery, June 1, 2003; 2(2): 138 - 142.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
F. J. Algar, A. Alvarez, A. Salvatierra, C. Baamonde, J. L. Aranda, and F. J. Lopez-Pujol
Predicting pulmonary complications after pneumonectomy for lung cancer
Eur. J. Cardiothorac. Surg., February 1, 2003; 23(2): 201 - 208.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
C. Alexiou, C.V. P. Onyeaka, D. Beggs, R. Akar, L. Beggs, F. D. Salama, J. P. Duffy, and W. E. Morgan
Do women live longer following lung resection for carcinoma?
Eur. J. Cardiothorac. Surg., February 1, 2002; 21(2): 319 - 325.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2001 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.